250 related articles for article (PubMed ID: 29333950)
21. [Overview of Ebola virus vaccine].
Yang L; Li J; Gao GF; Liu W
Sheng Wu Gong Cheng Xue Bao; 2015 Jan; 31(1):1-23. PubMed ID: 26021076
[TBL] [Abstract][Full Text] [Related]
22. Transmission, Human Population, and Pathogenicity: the Ebola Case in Point.
Delgado R; Simón F
Microbiol Spectr; 2018 Mar; 6(2):. PubMed ID: 29573259
[TBL] [Abstract][Full Text] [Related]
23. Contextual and psychosocial factors predicting Ebola prevention behaviours using the RANAS approach to behaviour change in Guinea-Bissau.
Gamma AE; Slekiene J; von Medeazza G; Asplund F; Cardoso P; Mosler HJ
BMC Public Health; 2017 May; 17(1):446. PubMed ID: 28506274
[TBL] [Abstract][Full Text] [Related]
24. A Risk Analysis Approach to Prioritizing Epidemics: Ebola Virus Disease in West Africa as a Case Study.
Ajisegiri WS; Chughtai AA; MacIntyre CR
Risk Anal; 2018 Mar; 38(3):429-441. PubMed ID: 28810081
[TBL] [Abstract][Full Text] [Related]
25. Willingness to participate in Ebola viral disease vaccine trials and receive vaccination by health workers in a tertiary hospital in Ile-Ife, Southwest Nigeria.
Olowookere SA; Abioye-Kuteyi EA; Adekanle O
Vaccine; 2016 Nov; 34(47):5758-5761. PubMed ID: 27751640
[TBL] [Abstract][Full Text] [Related]
26. Immunology of protection from Ebola virus infection.
Krause PR; Bryant PR; Clark T; Dempsey W; Henchal E; Michael NL; Regules JA; Gruber MF
Sci Transl Med; 2015 May; 7(286):286ps11. PubMed ID: 25947159
[TBL] [Abstract][Full Text] [Related]
27. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
[No Abstract] [Full Text] [Related]
28. Conceptions within misconceptions: Pluralisms in an Ebola vaccine trial in West Africa.
Alenichev A; Peeters Grietens K; Gerrets R
Glob Public Health; 2020 Jan; 15(1):13-21. PubMed ID: 31237180
[TBL] [Abstract][Full Text] [Related]
29. Factors That Mattered in Helping Travelers From Countries With Ebola Outbreaks Participate in Post-Arrival Monitoring During the 2014-2016 Ebola Epidemic.
Prue CE; Williams PN; Joseph HA; Johnson M; Wojno AE; Zulkiewicz BA; Macom J; Alexander JP; Ray SE; Southwell BG
Inquiry; 2019; 56():46958019894795. PubMed ID: 31847642
[TBL] [Abstract][Full Text] [Related]
30. Foreword.
Frieden TR
MMWR Suppl; 2016 Jul; 65(3):1-3. PubMed ID: 27389046
[TBL] [Abstract][Full Text] [Related]
31. Adenovirus-vectored Ebola vaccines.
Gilbert SC
Expert Rev Vaccines; 2015; 14(10):1347-57. PubMed ID: 26289977
[TBL] [Abstract][Full Text] [Related]
32. Development of vaccines for prevention of Ebola virus infection.
Ye L; Yang C
Microbes Infect; 2015 Feb; 17(2):98-108. PubMed ID: 25526819
[TBL] [Abstract][Full Text] [Related]
33. Ebola in West Africa--CDC's Role in Epidemic Detection, Control, and Prevention.
Frieden TR; Damon IK
Emerg Infect Dis; 2015 Nov; 21(11):1897-905. PubMed ID: 26484940
[TBL] [Abstract][Full Text] [Related]
34. [Overview of the Ebola vaccines in pre-clinical and clinical development].
Buchy P
Bull Soc Pathol Exot; 2016 Oct; 109(4):256-261. PubMed ID: 27646961
[TBL] [Abstract][Full Text] [Related]
35. Political drivers of epidemic response: foreign healthcare workers and the 2014 Ebola outbreak.
Nohrstedt D; Baekkeskov E
Disasters; 2018 Jan; 42(1):41-61. PubMed ID: 28440550
[TBL] [Abstract][Full Text] [Related]
36. UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments.
Noad RJ; Simpson K; Fooks AR; Hewson R; Gilbert SC; Stevens MP; Hosie MJ; Prior J; Kinsey AM; Entrican G; Simpson A; Whitty CJM; Carroll MW
Vaccine; 2019 Oct; 37(43):6241-6247. PubMed ID: 31522809
[TBL] [Abstract][Full Text] [Related]
37. Challenges and opportunities for China entering global research and development for emerging infectious diseases: a case study from Ebola experience.
Li C; Chen JY; Huang YM
Infect Dis Poverty; 2020 Mar; 9(1):27. PubMed ID: 32164743
[TBL] [Abstract][Full Text] [Related]
38. [Ebola vaccine, therapeutics, and diagnostics].
Furuyama W; Takada A
Uirusu; 2016; 66(1):63-72. PubMed ID: 28484180
[TBL] [Abstract][Full Text] [Related]
39. Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013-2016.
Breman JG; Heymann DL; Lloyd G; McCormick JB; Miatudila M; Murphy FA; Muyembé-Tamfun JJ; Piot P; Ruppol JF; Sureau P; van der Groen G; Johnson KM
J Infect Dis; 2016 Oct; 214(suppl 3):S93-S101. PubMed ID: 27357339
[TBL] [Abstract][Full Text] [Related]
40. Ebola Virus Epidemic in West Africa: Global Health Economic Challenges, Lessons Learned, and Policy Recommendations.
Elmahdawy M; Elsisi GH; Carapinha J; Lamorde M; Habib A; Agyie-Baffour P; Soualmi R; Ragab S; Udezi AW; Usifoh C; Usifoh S
Value Health Reg Issues; 2017 Sep; 13():67-70. PubMed ID: 29073992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
